CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $52,000 | +67.7% | 37,600 | +29.7% | 0.00% | – |
| Q4 2018 | $31,000 | -66.3% | 29,000 | +93.3% | 0.00% | – |
| Q3 2018 | $92,000 | -42.5% | 15,000 | 0.0% | 0.00% | – |
| Q2 2018 | $160,000 | -0.6% | 15,000 | 0.0% | 0.00% | – |
| Q1 2018 | $161,000 | +53.3% | 15,000 | 0.0% | 0.00% | – |
| Q4 2017 | $105,000 | -19.8% | 15,000 | 0.0% | 0.00% | – |
| Q3 2017 | $131,000 | -4.4% | 15,000 | 0.0% | 0.00% | – |
| Q2 2017 | $137,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |